Cargando…
Evolutionary cancer-favoring engineered vaccinia virus for metastatic hepatocellular carcinoma
Engineered vaccinia virus-based therapy shows promising results in patients with advanced hepatocellular carcinoma, although a strategic virus design for the metastatic liver and the study of its efficacy in treating the cancer has not been well assessed. In this paper, we proposed a simple and stra...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641064/ https://www.ncbi.nlm.nih.gov/pubmed/29069721 http://dx.doi.org/10.18632/oncotarget.17288 |